Immediate Impact

10 standout
Sub-graph 1 of 4

Citing Papers

Advances and prospects of biomarkers for immune checkpoint inhibitors
2024 Standout
Unveiling the mechanisms and challenges of cancer drug resistance
2024 Standout
2 intermediate papers

Works of Conrad‐Amadeus Voltin being referenced

Early Response to First-Line Anti–PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial
2020

Author Peers

Author Last Decade Papers Cites
Conrad‐Amadeus Voltin 170 147 79 22 253
Jasmin Mettler 163 122 70 15 205
D. Gilson 91 66 86 21 288
Cristina Piva 134 95 102 24 311
Sara Bartoncini 63 95 129 29 269
E.M. Osborne 132 65 73 16 205
R. Quek 184 58 63 20 247
A Goßmann 106 76 143 24 331
Ling Chen 197 88 63 28 335
Anna Borra 55 147 81 16 309
Diana Libster 183 59 72 16 294

All Works

Loading papers...

Rankless by CCL
2026